Latest Blogs

Sep 21, 2017
"At different points in the retreat, I felt indebted to the women who came before me... and renewed by the ideas we all have to make a world of difference in cancer care," writes Dr. Stephanie Graff.
Sep 15, 2017
When a new patient comes to see you about a cancer diagnosis, think about the invisible things they may be carrying to the visit, such as fear, anxiety, sleepless nights, financial worries, and concern for their loved ones.
Sep 14, 2017
Dr. Dinesh Pendharkar outlines the current work of ASCO's International Affairs Committee. A particular emphasis this year is fostering clinical research in oncology through capacity and skill development.
Sep 12, 2017
As fellows, we are the faculty members and program directors of tomorrow, so it really is up to us to make sense of how to maintain the necessary rigor to get through medical training but also how to live and let live while doing it.
Subscribe to this column

Don S. Dizon, MD, FACP

Don S. Dizon, MD, FACP, is is head of Women's Cancers at Lifespan Cancer Institute, director of Medical Oncology at Rhode Island Hospital, and an associate professor of medicine at The Warren Alpert Medical School of Brown University. Dr. Dizon serves as chair of ASCO's Social Media Working Group and is a past chair of the Cancer Communications Committee. In addition to his regular column on ASCOconnection.org, which has been honored with APEX awards in 2013 and 2014, he is a blogger for The Oncologist and a section editor of Gynecologic Oncology at UpToDate. Dr. Dizon is a member of the Journal of Clinical Oncology Editorial Board, and editor in chief of the ASCO Educational Book. Follow Dr. Dizon on Twitter @drdonsdizon.

Sep 12, 2017
I applaud the Foundation for Women’s Cancers for highlighting the importance of trials, and join them in their push for more trial options for not only my own patients, but for all patients with cancer.
Aug 29, 2017
As I prepare to take on a new professional position, I have been reflecting on what academic medicine means, and how to thrive in it.
Aug 01, 2017
Yes, "at least" my patient was still alive. But, at the end of the day, I knew that would not be comforting. “At least” is never enough, because when it comes to life, most of us—cancer or no cancer—always want more.
Jun 20, 2017
New immunotherapies are offering astounding responses, but my patient's remission came at the cost of debilitating toxicity. How much is too much to bear?
Jun 08, 2017
At the Plenary Session of this year’s ASCO Annual Meeting, the results of a longitudinal trial begun in 2007 showed me that patient engagement is much more important that I had imagined.
May 30, 2017
The phrase "the fight against cancer" assumes only two outcomes: remission or death, no middle ground. Today more than ever, nothing is further from reality.

Pages